Literature DB >> 24692417

Changes in patterns of injecting drug use in Hungary: a shift to synthetic cathinones.

Anna Péterfi1, Anna Tarján, Gergely Csaba Horváth, Tamás Csesztregi, Adrienn Nyírády.   

Abstract

The spread of synthetic cathinone injecting is a new phenomenon observed in recent years in Hungary. Until 2010, when the first anecdotal reports on cathinone injecting appeared, injecting was associated with the use of heroin and amphetamine. In this paper we review available evidence of the changes in the drug market and a concurrent shift in patterns of injecting drug use that have been taking place in Hungary since 2010. Remarkable changes have been observed in police seizures data since 2010. While new psychoactive substances have appeared, the availability of heroin has dropped significantly. A qualitative study in 2011 revealed that these market changes correlate with changes in patterns of injecting drug use: decreasing heroin use and the appearance of mephedrone injecting were reported by treatment and needle and syringe programme (NSP) personnel. These changes are detectable in other routine epidemiological data collection systems in the following years as well (i.e. treatment, drug-related deaths, NSP clientele). Heroin-related treatment demand dropped, as did heroin-related mortality. Parallel to this, a growing number of clients appeared in treatment and in NSPs who were primarily injecting cathinones. The shift to cathinones can be observed in amphetamine and heroin injectors as well. Monitoring changes in patterns of injecting drug use are especially important because of the vulnerability of this drug-user population and the consequences of this high-risk route of drug administration. The realignment observed in Hungary is to be further investigated with regard to its determinants, changes in risk behaviour, and in treatment needs.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  heroin shortage; injecting drugs use; patterns of use; synthetic cathinones

Mesh:

Substances:

Year:  2014        PMID: 24692417     DOI: 10.1002/dta.1625

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  5 in total

1.  Synthesis, characterization and monoamine transporter activity of the new psychoactive substance mexedrone and its N-methoxy positional isomer, N-methoxymephedrone.

Authors:  Gavin McLaughlin; Noreen Morris; Pierce V Kavanagh; John D Power; Geraldine Dowling; Brendan Twamley; John O'Brien; Brian Talbot; Donna Walther; John S Partilla; Michael H Baumann; Simon D Brandt
Journal:  Drug Test Anal       Date:  2016-09-21       Impact factor: 3.345

Review 2.  Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health.

Authors:  Aviv M Weinstein; Paola Rosca; Liana Fattore; Edythe D London
Journal:  Front Psychiatry       Date:  2017-08-23       Impact factor: 4.157

3.  A Recent Human Immunodeficiency Virus Outbreak Among People Who Inject Drugs in Munich, Germany, Is Associated With Consumption of Synthetic Cathinones.

Authors:  Kirsten Hanke; Stefan Fiedler; Christina Grumann; Oliver Ratmann; Andrea Hauser; Patrycja Klink; Karolin Meixenberger; Britta Altmann; Ruth Zimmermann; Ulrich Marcus; Viviane Bremer; Volker Auwärter; Norbert Bannert
Journal:  Open Forum Infect Dis       Date:  2020-05-27       Impact factor: 3.835

4.  Substance Use Disorders and COVID-19: Multi-Faceted Problems Which Require Multi-Pronged Solutions.

Authors:  Wossenseged Birhane Jemberie; Jennifer Stewart Williams; Malin Eriksson; Ann-Sofie Grönlund; Nawi Ng; Marcus Blom Nilsson; Mojgan Padyab; Kelsey Caroline Priest; Mikael Sandlund; Fredrik Snellman; Dennis McCarty; Lena M Lundgren
Journal:  Front Psychiatry       Date:  2020-07-21       Impact factor: 4.157

5.  Childhood Trauma, Cognitive Emotion Regulation and Motivation for Behavior Change Among Clients of Opioid Substitution Treatment With and Without Past Year Synthetic Cathinone Use During Therapy.

Authors:  Máté Kapitány-Fövény; Anna Kiss; Judit Farkas; Kinga Edit Kuczora; Patrícia Pataki; Janka Horváth; Zsolt Demetrovics
Journal:  Front Neurosci       Date:  2020-01-31       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.